Samrat Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE103E01016
NSEID:
BSEID: 530125

INR

234.70

4.7 (2.04%)

BSENSE

Dec 30

BSE+NSE Vol: 320

{
  "main_header": {
    "sid": 116063,
    "name": "Samrat Pharma",
    "stock_name": "Samrat Pharma",
    "full_name": "Samrat Pharmachem Ltd",
    "name_url": "stocks-analysis/samrat-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "234.70",
    "chg": 4.7,
    "chgp": "2.04%",
    "dir": 1,
    "prev_price": "230.00",
    "mcapval": "72.52 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530125,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE103E01016",
    "curr_date": "Dec 30",
    "curr_time": "",
    "bse_nse_vol": "320 ",
    "exc_status": "Active",
    "traded_date": "Dec 30, 2025",
    "traded_date_str": "2025 12 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/samrat-pharma-116063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Samrat Pharmachem Ltd Stock Falls to 52-Week Low of Rs.224.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-stock-falls-to-52-week-low-of-rs22495-3773399",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SamratPharmache_priceRelatedfactors_3773399.png",
        "date": "2025-12-29 11:06:01",
        "description": "Samrat Pharmachem Ltd’s stock declined to a fresh 52-week low of Rs.224.95 on 29 Dec 2025, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and benchmark indices, reflecting persistent pressures on its financial and market performance."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3769822",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SamratPharmache_mojoScore_3769822.png",
        "date": "2025-12-25 15:12:28",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 August 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Why is Samrat Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-samrat-pharma-fallingrising-3762999",
        "imagepath": "",
        "date": "2025-12-19 01:41:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Samrat Pharmachem’s share price has been under pressure for several sessions, with the stock recording losses for four consecutive days, resulting in a cumulative decline of 10.51% over this period. On 18-Dec, the stock opened with a gap down of 3.91%, signalling immediate bearish sentiment among investors. Throughout the trading day, the price touched an intraday low of ₹226, establishing a new 52-week low and underscoring the persistent weakness in the stock.</p>\n<p>The weighted average price for the day indicates that a greater volume of shares was traded closer to the lower end of the price range, suggesting that sellers dominated the session. This selling pressure is further reflected in the fact that Samrat Pharmachem is currentl..."
      },
      {
        "title": "Samrat Pharmachem Falls to 52-Week Low of Rs.230.05 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-stock-falls-to-52-week-low-of-rs23005-amidst-continued-downtrend-3762234",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SamratPharmache_priceRelatedfactors_3762234.png",
        "date": "2025-12-18 09:41:01",
        "description": "Samrat Pharmachem’s stock price reached a fresh 52-week low of Rs.230.05 today, marking a significant decline amid a sustained downward trend. The stock has experienced a series of losses over the past four trading sessions, culminating in a cumulative return of -9.65% during this period, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Samrat Pharmachem Falls to 52-Week Low of Rs.237 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-stock-falls-to-52-week-low-of-rs237-amidst-continued-downtrend-3753408",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SamratPharmache_priceRelatedfactors_3753408.png",
        "date": "2025-12-09 09:49:01",
        "description": "Samrat Pharmachem's stock price reached a fresh 52-week low of Rs.237 today, marking a significant decline amid ongoing downward momentum. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market factors that have influenced its performance over the past year."
      },
      {
        "title": "Samrat Pharma’s Evaluation Revised Amidst Challenging Financial and Market Conditions",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharma-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-outlook-3749906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SamratPharma_mojoScore_3749906.png",
        "date": "2025-12-06 10:10:05",
        "description": "Samrat Pharma, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing operational and financial challenges. This shift highlights the company’s current standing amid a difficult market environment and evolving investor perspectives."
      },
      {
        "title": "Samrat Pharmachem Stock Falls to 52-Week Low of Rs.250",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-stock-hits-52-week-low-amidst-continued-underperformance-3738337",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SamratPharmache_priceRelatedfactors_3738337.png",
        "date": "2025-12-01 11:08:07",
        "description": "Samrat Pharmachem's shares reached a fresh 52-week low of Rs.250 today, marking a significant decline amid broader market gains. The stock underperformed its sector and key benchmarks, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology space."
      },
      {
        "title": "Samrat Pharmachem Stock Falls to 52-Week Low of Rs.251 Amidst Prolonged Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-stock-hits-52-week-low-amidst-continued-underperformance-3731424",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SamratPharmache_priceRelatedfactors_3731424.png",
        "date": "2025-11-26 12:46:33",
        "description": "Samrat Pharmachem’s shares touched a fresh 52-week low of Rs.251 today, marking a significant price level amid a year of sustained underperformance relative to the broader market and sector peers."
      },
      {
        "title": "Samrat Pharmachem Falls to 52-Week Low of Rs.265 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-stock-hits-52-week-low-amidst-continued-downtrend-3725710",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SamratPharmache_priceRelatedfactors_3725710.png",
        "date": "2025-11-24 14:36:34",
        "description": "Samrat Pharmachem’s stock price reached a fresh 52-week low of Rs.265 today, marking a significant decline amid ongoing downward momentum. The pharmaceutical and biotechnology company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year."
      }
    ],
    "total": 5730,
    "sid": "116063",
    "stock_news_url": "https://www.marketsmojo.com/news/samrat-pharmachem-116063"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "02-Dec-2025",
      "details": "Crisil Ltd has downgraded its rating to CrisilBB+/Negative/CrisilA4+",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "20-Nov-2025",
      "details": "Newspaper Publication - Extract of Results for the quarter and half year ended September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today",
      "datetime": "14-Nov-2025",
      "details": "The Board of Directors considered and took on record the Un-audited Standalone Financial Results for the quarter and half year ended September 30 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Samrat Pharmachem Ltd has declared <strong>10%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Samrat Pharmachem Ltd Stock Falls to 52-Week Low of Rs.224.95

2025-12-29 11:06:01

Samrat Pharmachem Ltd’s stock declined to a fresh 52-week low of Rs.224.95 on 29 Dec 2025, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and benchmark indices, reflecting persistent pressures on its financial and market performance.

Samrat Pharmachem Ltd is Rated Strong Sell

2025-12-25 15:12:28

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 August 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Why is Samrat Pharma falling/rising?

2025-12-19 01:41:31

Recent Price Movement and Market Context

Samrat Pharmachem’s share price has been under pressure for several sessions, with the stock recording losses for four consecutive days, resulting in a cumulative decline of 10.51% over this period. On 18-Dec, the stock opened with a gap down of 3.91%, signalling immediate bearish sentiment among investors. Throughout the trading day, the price touched an intraday low of ₹226, establishing a new 52-week low and underscoring the persistent weakness in the stock.

The weighted average price for the day indicates that a greater volume of shares was traded closer to the lower end of the price range, suggesting that sellers dominated the session. This selling pressure is further reflected in the fact that Samrat Pharmachem is currentl...

Samrat Pharmachem Falls to 52-Week Low of Rs.230.05 Amidst Prolonged Downtrend

2025-12-18 09:41:01

Samrat Pharmachem’s stock price reached a fresh 52-week low of Rs.230.05 today, marking a significant decline amid a sustained downward trend. The stock has experienced a series of losses over the past four trading sessions, culminating in a cumulative return of -9.65% during this period, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Samrat Pharmachem Falls to 52-Week Low of Rs.237 Amidst Continued Downtrend

2025-12-09 09:49:01

Samrat Pharmachem's stock price reached a fresh 52-week low of Rs.237 today, marking a significant decline amid ongoing downward momentum. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market factors that have influenced its performance over the past year.

Samrat Pharma’s Evaluation Revised Amidst Challenging Financial and Market Conditions

2025-12-06 10:10:05

Samrat Pharma, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing operational and financial challenges. This shift highlights the company’s current standing amid a difficult market environment and evolving investor perspectives.

Samrat Pharmachem Stock Falls to 52-Week Low of Rs.250

2025-12-01 11:08:07

Samrat Pharmachem's shares reached a fresh 52-week low of Rs.250 today, marking a significant decline amid broader market gains. The stock underperformed its sector and key benchmarks, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology space.

Samrat Pharmachem Stock Falls to 52-Week Low of Rs.251 Amidst Prolonged Underperformance

2025-11-26 12:46:33

Samrat Pharmachem’s shares touched a fresh 52-week low of Rs.251 today, marking a significant price level amid a year of sustained underperformance relative to the broader market and sector peers.

Samrat Pharmachem Falls to 52-Week Low of Rs.265 Amidst Continued Downtrend

2025-11-24 14:36:34

Samrat Pharmachem’s stock price reached a fresh 52-week low of Rs.265 today, marking a significant decline amid ongoing downward momentum. The pharmaceutical and biotechnology company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year.

View All News

Announcement

Announcement under Regulation 30 (LODR)-Credit Rating

02-Dec-2025 | Source : BSE

Crisil Ltd has downgraded its rating to CrisilBB+/Negative/CrisilA4+

Announcement under Regulation 30 (LODR)-Newspaper Publication

20-Nov-2025 | Source : BSE

Newspaper Publication - Extract of Results for the quarter and half year ended September 30 2025

Board Meeting Outcome for Outcome Of Board Meeting Held Today

14-Nov-2025 | Source : BSE

The Board of Directors considered and took on record the Un-audited Standalone Financial Results for the quarter and half year ended September 30 2025.